During the past decade, CCOP - Columbus conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 168 clinical trials were completed, i.e. on average, 541.9% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 52 clinical trials were completed. i.e. 742.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CCOP - Columbus" #1 sponsor was "SWOG Cancer Research Network" with 117 trials, followed by "National Cancer Institute (NCI)" with 72 trials sponsored, "Alliance for Clinical Trials in Oncology" with 58 trials sponsored, "Radiation Therapy Oncology Group" with 52 trials sponsored and "Eastern Cooperative Oncology Group" with 52 trials sponsored. Other sponsors include 77 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CCOP - Columbus" #1 collaborator was "National Cancer Institute (NCI)" with 329 trials as a collaborator, "SWOG Cancer Research Network" with 26 trials as a collaborator, "Cancer and Leukemia Group B" with 25 trials as a collaborator, "Eastern Cooperative Oncology Group" with 24 trials as a collaborator and "NRG Oncology" with 24 trials as a collaborator. Other collaborators include 81 different institutions and companies that were collaborators in the rest 37 trials.

According to Clinical.Site data, the most researched conditions in "CCOP - Columbus" are "Breast Cancer" (59 trials), "Lung Cancer" (38 trials), "Lymphoma" (26 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (23 trials) and "Prostate Cancer" (22 trials). Many other conditions were trialed in "CCOP - Columbus" in a lesser frequency.

Most popular intervention types in "CCOP - Columbus" are "Drug" (330 trials), "Other" (131 trials), "Biological" (113 trials), "Radiation" (88 trials) and "Procedure" (66 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (63 trials), "radiation therapy" (56 trials), "Quality-of-Life Assessment" (35 trials), "cisplatin" (31 trials) and "placebo" (31 trials). Other intervention names were less common.

The vast majority of trials in "CCOP - Columbus" are 308 trials for "All" genders, 84 trials for "Female" genders and 24 trials for "Male" genders.

Currently, there are NaN active trials in "CCOP - Columbus". undefined are not yet recruiting, 4 are recruiting, 64 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 306 completed trials in CCOP - Columbus, undefined suspended trials, and 35 terminated clinical trials to date.

Out of the total trials that were conducted in CCOP - Columbus, 19 "Phase 1" clinical trials were conducted, 187 "Phase 2" clinical trials and 190 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 18 trials that are defined as “Not Applicable".